Initimation of Closure of trading window for the quater ending 30th June, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has informed the stock exchanges that the trading window for dealing in the company's shares will be closed for designated persons and their immediate relatives with effect from the end of the quarter, i.e., 30th June 2025. This is a routine compliance measure under SEBI's Insider Trading Regulations, applied ahead of the declaration of unaudited financial results for the quarter. The trading window typically remains shut until 48 hours after the results are announced to the public. No financial figures, transactions, or material developments have been disclosed in this filing.
This is a standard regulatory filing with no direct impact on shareholders or the stock price. It simply restricts insiders from trading until results are published, ensuring fairness and preventing leakage of unpublished financial information.